investigated the potential of a photodynamic immunostimulant consisting of a photosensitizer (dihydroporphyrin e6), an ASCT2 inhibitor (V9302), and a PD1/PDL1 blocker (BMS-1) to inhibit glutamine transport and GSH synthesis by targeting glutamine metabolism
Characterization of a delta electroencephalogram-sleep-inducing peptide DSIP: a review of its functional significance
Comprehensive in vitro models, including human skin S9 fraction, kidney S9 fraction and biological fluids, were used to investigate metabolic pathways
The receptor also shows notably high constitutive (ligand-independent) activity, a feature that distinguishes it from many other G-protein-coupled receptors and that shapes how agonists like MK-677 behave
In targeted therapy, GSH depletion prevents redox-driven adaptive resistance to PI3K/AKT/mTOR, MAPK, and KRAS inhibitors, intensifying oxidative stress and restoring drug sensitivity
Redox regulation of hepatocyte apoptosis